# Trigger Point Injection in Reducing Pain Following Total Knee Arthroplasty

> **NCT06955923** · PHASE2 · COMPLETED · sponsor: **David Grant U.S. Air Force Medical Center** · enrollment: 11 (actual)

## Conditions studied

- Trigger Point Pain, Myofascial

## Interventions

- **DRUG:** Trigger point injection (lidocaine)
- **OTHER:** Sham Comparator

## Key facts

- **NCT ID:** NCT06955923
- **Lead sponsor:** David Grant U.S. Air Force Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-30
- **Primary completion:** 2025-08-25
- **Final completion:** 2025-08-26
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06955923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06955923, "Trigger Point Injection in Reducing Pain Following Total Knee Arthroplasty". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT06955923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*